AMRI is a contract research organization with nearly 20 years experience providing customers fully integrated drug discovery, development and small and large scale manufacturing services.
AMRI is a contract research organization with nearly 20 years experience providing customers fully integrated drug discovery, development and small and large scale manufacturing services.
Comprised of 1350+ employees, we have worked with companies in the pharmaceutical, biotechnology, medical, cosmetic and food industries, as well as not-for-profit organizations and educational institutions.
Providing a broad spectrum of services by a team of scientists with an average global Ph.D. density of 50%, AMRI delivers intellectual input, expertise and renowned problem-solving skills “on the bench.”
With locations throughout the world, AMRI has an unmatched ability to provide globally integrated solutions using flexible business models. Most recently, in February 2010, AMRI acquired Excelsyn Ltd (now AMRI UK) in Holywell, Wales, and can now offer customers European-based development and manufacturing capabilities with convenient access to discovery services through our Hungary facility. Additional capabilities and expertise are available in conjunction with our United States and Asia locations.
Recognized as premier provider of CRO services, AMRI is committed to providing the highest quality services and products to its customers.
To learn more about AMRI and our new cost-effective solutions in Europe, contact us at (518) 512-2000 or visit www.amriglobal.com
Drug Solutions Podcast: Novel Drug Delivery Approaches: Refining AAV Vector Deliveries
May 30th 2025In this podcast episode, we discuss novel approaches to drug delivery, specifically regarding adeno-associated virus (AAV) vectors, as viewed by two industry experts who recently exhibited at the annual ASGCT meeting.
Transformations in Drug Development for Cell and Gene Therapies
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.